Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells

Journal of Cellular Physiology

Volumn 177, Issue 2, 1998, Pages 299-312

  Burg, Michael A ^a   Grako, Kathryn A ^a   Stallcup, William B ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; MONOCLONAL ANTIBODY; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; TUMOR GROWTH;

ANIMALS; ANTIGENS; ANTIGENS, CD44; CELL ADHESION; CELL DIVISION; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; RATS; RECEPTORS, LYMPHOCYTE HOMING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031685581     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199811)177:2<299::AID-JCP12>3.0.CO;2-5     Document Type: Article

References (71)

1. Albelda, S.M., Mette, S.A., Elder, D.E., Stewart, R-M., Damjanovich, L., Herlyn, M., and Buch, C.A. (1990) Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression. Cancer Res., 50:6757-6764.
2. Aubert, C., Rouge, F., and Voulot, C. (1990) New variants of the B16 melanoma: Tumorigenicity and metastatic properties under different culture conditions. J. Natl. Cancer Inst., 82:952-958.
3. Barnhill, R.L., Xiao, M., Graves, D., and Antoniades, H.N. (1996) Expression of platelet-derived growth factor PDGF-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo. Br. J. Dermatol., 135:898-904.
4. Bartolazzi, A., Peach, R., Aruffo, A., and Stamekovic, I. (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med., 180:53-66.
5. Behm, F.G., Smith, F.O., Raimondi, S.C., Pui, C.-H., and Bernstein, I.D. (1996) Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;13) and MLL gene rearrangements. Blood, 87:1134-1139.
6. Bertrand, P., Girard, N., Delpech, B., Duval, C., D'Anjou, J., and Dauce, J.P. (1992) Hyaluronan and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and non-invasive areas. Int. J. Cancer, 52:1-6.
7. Birch, M., Mitchell, S., and Hart, I.R. (1991) Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res., 51:6660-6667.
8. Bumol, T.F., Wang, Q.C., Reisfeld, R.A., and Kaplan, N.O. (1983) Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. Proc. Natl. Acad. Sci. U.S.A., 80:529-533.
9. Bumol, T.F., Walker, L.E., and Reisfeld, R.A. (1984) Biosynthetic studies of proteoglycans in human melanoma cells with a monoclonal antibody to a core glycoprotein of chondroitin sulfate proteoglycans. J. Biol. Chem. 259:12733-12741.
10. Burg, M.A., Tillet, E., Timpl, R., and Stallcup, W.B. (1996) Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J. Biol. Chem., 271:26110-26116.
11. Burg, M.A., Nishiyama, A., and Stallcup, W.B. (1997) A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp. Cell Res. 235: 254-264.
12. Burridge, K. (1986) Substrate adhesions in normal and transformed fibroblasts: Organization and regulation of cytoskeletal, membrane, and extracellular matrix components at focal contacts. Cancer Res., 4:18-78.
13. Carter, W.G., and Wayner, E.A. (1988) Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem., 263:4193-4201.
14. Chen, W.T., Wang, J., Hasegawa, T., Yamada, S., and Yamada, K. (1986) Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin, and synthetic peptides. J. Cell Biol., 103:1649-1661.
15. Dou, C.-L., and Levine, J.M. (1994) Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci., 14:7616-7628.
16. East, J.A., Mitchell, S.D., and Hart, I.R. (1993) Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res., 3:341-346.
17. Edward. M. (1995) Integrins and other adhesion molecules involved in melanocytic tumor progression. Curr. Opin. Oncol., 7:185-191.
18. Fidler, I.S. (1973) Selection of successive tumor lines for metastasis. Nature, 242:148-149.
19. Gehlsen, K.R., Davis, G.E., and Sriramarao, P. (1992) Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. Exp. Metastasis, 10:111-120.
20. 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60:849-859.
21. Giuffre, L., Schreyer, M., Mach, J.-P., and Carrel, S. (1987) Cyclic AMP induces differentiation in vitro of human melanoma cells. Cancer, 61:1132-1141.
22. Gordon, M.Y., Dowding, C.R., Riley, G.P., Goldman, J.M., and Greaves, M.F. (1987) Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukemia. Nature (Lond.), 328:342-344.
23. Grako. K., and Stallcup, W.B. (1995) Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp. Cell Res. 221:231-240.
24. Gunthert, U., Stauder, R., Mayer, B., Terpe, H-J., Finke, L., and Friedrichs, K. (1995) Are CD44 variant isoforms involved in human tumour progression? Cancer Surv., 24:19-41.
25. Halaban, R. (1991) Growth factors regulating normal and malignant melanocytes. In: Melanoma Research: Genetics, Growth Factors, Metastases, and Antigens. L. Nathanson, ed. Kluwer Academic Publishers, Boston, pp. 19-40.
26. Harper, J.R., and Reisfeld, R.A. (1983) Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan. J. Natl. Cancer Inst., 71:259-263.
27. Harper, J.R., and Reisfeld, R.A. (1987) Cell-associated proteoglycans in human malignant melanoma. In: Biology of Proteoglycans. T. Wight, and R. Mecham, eds. Academic Press, Inc., Orlando, FL. pp. 345-366.
28. Hart, I.R., Birch, M., and Marshall, J.F. (1991) Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev., 10:115-128.
29. Herlyn, M. (1990) Human melanoma: Development and progression. Cancer Metastasis Rev., 9:101-112.
30. Houghton, A.N., Eisinger, M., Albino, A.P., Cairncross, J.G., and Old, L.J. (1982) Surface antigens of melanocytes and melanoma: Markers of melanocyte differentiation and melanoma subsets. J. Exp. Med., 156:1755-1166.
31. Houghton, A.N., Real, F.X., Davis, L.J., Cordon-Cardo, C. and Old, L.J. (1987) Phenutypic heterogeneity of melanoma. J. Exp. Med., 164:812-829.
32. Hurley, R.W., McCarthy, J.B., and Verfaillie, C.M. (1995) Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J. Clin. Invest., 96:511-519.
33. 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. Exp. Hematol., 25:321-328.
34. 1 intergrin. Cancer Res., 55:2177-2185.
35. Jones, V.E., and Mitchell, M.S. (1996) Therapeutic vaccines for melanoma: Progress and problems. TIBTECH., 14:349-355.
36. 1. Cell Adhes. Commun., 3:487-495.
37. Karasawa, K., Sugiura, N., Hori, Y., Suzuki, S., Onaya, J., Sakurai, K., and Kinata, K. (1997) Inhibition of experimental metastasis and cell adhesion of murine melanoma cells by chondroitin sulfate-derivatized lipid, a neoproteoglycan with anti-cell adhesion activity. Clin. Exp. Metastasis, 15:83-93.
38. 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol. Cell, 7:383-396.
39. Kozlowski, J.M., Hart, I.R., Fidler, I.J., and Hanna, N. (1984) A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst., 72:913-917.
40. Kramer, R.H., Vu, M., Cheng, Y-F., and Ramos, D.M. (1991) Integrin expression in malignant melanoma. Cancer Metastasis Rev., 10:49-59.
41. Liotta, L.A., Steeg, P.S., and Steler-Stevenson, W.G. (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell, 64:327-336.
42. Liu, B., Earl, H.M., Baban, D., Shoaibi, M., Fabra, A., Kerr, D.J., and Seymour, L.W. (1995) Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem. Biophys. Res. Commun., 217:721-727.
43. Lundell, B.I., McCarthy, J.B., Kovach, N.L., and Verfaillie, C.M. (1997) Activation of beta-1 integrins on CML progenitors reveals cooperation between beta-1 integrins and CD44 in the regulation of adhesion and proliferation. Leukemia, 11:822-829.
44. Margolis, R.U., and Margolis, R.K. (1996) Counteradhesive properties of chondroitin sulfate proteoglycans. In: Tenascin and Counter Adhesive Molecules of the Extracellular Matrix. K.L. Crossin, ed. Harwood Academic Publishers, Amsterdam. pp. 145-159.
45. Mortarini, R., and Anichini. A. (1993) From adhesion to signalling: Roles of integrins in the biology of human melanoma. Melanoma Res., 3:87-97.
46. 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J., 10:4089-4095.
47. Naujokas, N.F., Morin, M., Anderson, M.S., Peterson, M., and Miller, J. (1993) The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell, 74:257-268.
48. Nishiyama, A., and Stallcup, W.B. (1993) Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol. Biol. Cell, 4:1097-1108.
49. Nishiyama, A., Dahlin, K.J., Prince, J.T., Johnstone, S.R., and Stallcup, W.B. (1991a) The primary structure of NG2, a novel membrane-spanning proteoglycan. J. Cell Biol., 114:359-371.
50. Nishiyama, A., Dahlin, K.J., and Stallcup, W.B. (1991b) The expression of NG2 proteoglycan in the developing rat limb. Development, 111:933-944.
51. Nishiyama, A., Lin, X-H., Giese, N., Heldin, C-H., and Stallcup, W.B. (1996a) Co-localization of NG2 proteoglycan and PDGF α receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. Res., 43:299-314.
52. Nishiyama, A., Lin, X-H., Giese, N., Heldin, C-H., and Stallcup, W.B. (1996b) Interaction between NG2 proteoglycan and PDGF α receptor is required for optimal response to PDGF. J. Neurosci Res., 43:315-330.
53. Plantefaber, L., and Hynes, R. (1989) Changes in integrin receptors on oncogenically transformed cells. Cell, 56:281-290.
54. Pluschke, G., Vanek, M., Evans, A., Dittmar, T., Schmid, P., Itin, P., Filardo, E., and Reisfeld, R. (1996) Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc. Nat. Acad. Sci. U.S.A., 93:9710-9715.
55. Rand, J.H., Patel., N.D., Schwartz, E., Zhou, S.-L., and Potter, B.J. (1991) 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J. Clin. Invest., 88:253-259.
56. Real, F.X., Houghton, A.N., Albino, A.P., Cordon-Cardo, C., Melamed, M.R., Oettgen, H.F., and Old, L.J. (1985) Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res., 45:4401-4411.
57. Ruoslahti, E. (1988) Fibronectin and its receptors, Annu. Rev. Biochem., 57:375-413.
58. Rusciano, D., and Burger, M.M. (1993) Mechanisms of metastasis. In: Molecular Genetics of Nervous System Tumors. A.J. Levine, and H.H. Schmidek, eds. Wiley-Liss, Inc., New York, pp. 357-369.
59. Rusciano, D., Lorenzoni, P., and Burger, M.M. (1992) Specific growth stimulation in the absence of specific cellular adhesion in lung carcinoma by retinoic-acid-treated F9 teratocarcinoma cells. Int. J. Cancer, 52:471-477.
60. Shih, I.,-E., and Herlyn, M. (1994) Autocrine and paracrine roles for growth factors in melanoma. In Vivo, 8:113-124.
61. Smith, F.O., Rauch, C., Williams, D.E., March, C.J., Arthur, D., Hilden, J., Lampkin, B.C., Buckley, J.D., Buckley, C.V., Woods, W.G., Dinndorf, P.A., Sorensen, P., Kersey, J., Hammond, D., and Bernstein, I.D. (1996) The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Blood, 87:1123-1133.
62. Stallcup, W.B., Dahlin, K., and Healy, P. (1990) Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J. Cell Biol., 111:3177-3188.
63. Sy, M., Guo, Y., and Stamenkovic, I. (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med., 174:869-866.
64. Tillet, E., Ruggiero, F., Nishiyama, A., and Stallcup, W.B. (1997) The membrane-spanning proteoglycan NG2 binds to collagen V and VI through the central non-helical portion of the ectodomain. J. Biol. Chem., 272:10769-10776.
65. Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y., Kitamura, F., Yagita, H., Suzuki, K., and Miyasaka, M. (1995) A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. J. Biol. Chem., 270:7437-7444.
66. Tsukamoto, K., Gersten, D.M., Law, L.W., and Hearing, V.J. (1991) Malignant melanoma: Relationship to parameters of differentiation. Melanoma Res., 1:223-230.
67. van Muijen, G., Danen, E., Veerkamp, J., Ruiter, D., Lesley, J., and van den Heuvel, L. (1994) Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int. J. Cancer, 61:241-248.
68. 1 and CD44 adhesion receptor. Blood, 84:1802-1811.
69. Vile, R.G. (1995) The metastatic cascade. In: Cancer Metastasis: From Mechanisms to Therapies. R.G. Vile, ed. Imperial Cancer Research Fund, London, UK, pp. 1-20.
70. Xie, S., Luca, M., Huang, S., Gutman, M., Reich, R., Johnson, J.P., and Bar-Eli, M. (1997) Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res., 57:2295-2303.
71. Zhang, L., Underhill, C.B., and Chen, L. (1995) Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55:428-433.